API and drug product CDMO reports rapid growth in MAH programs in China

3 Dec 2017

Since the MAH pilot launch, the company has undertaken eight development programs.

STA Pharmaceutical reports that it has seen a rapid uptake in companies with intent to market their products in China, using it as a development and manufacturing partner following the CFDA’s announcement of the new Market Authorization Holder (MAH) pilot program last year in China. The pilot was launched to allow drug license holders to use qualified contract manufacturing service providers in certain geographic areas (10 trial provinces and municipalities), thereby increasing innovation as biotechs would no longer need to invest in their own manufacturing facilities.

API and drug product CDMO reports rapid growth in MAH programs in China

Since STA has existing CFDA-approved facilities in China – at both development and commercial scale – and extensive experience with the pilot program, it is poised to be one of the biggest participants of the MAH projects for innovative new chemical entities (NCE). In just the first full year of the pilot, STA is already undertaking the development work for eight NCE projects – the most of any domestic CDMO in the country.

“We have seen very quick take-up amongst the Chinese pharma and biotech sectors in 2017. But we anticipate an acceleration of demand next year as both Chinese customers and, increasingly western drug makers looking to file NDAs in China, begin programs with us,” commented Ms. Mei Hao, Vice President of Quality Assurance at STA.

In 2018, STA forecasts to continue carrying on 10+ MAH projects, as demand for contract services in China increases quickly. Mei added: "The benefit to speed the new drug into the market for the innovators is huge, which saves vital time and costs. But for STA it’s also a huge opportunity, as we have experience of working with MAH type programs via our experience with FDA and EMA, not to mention facilities approved by all the major regulators. We are ideally placed to be the contract provider of choice as the program matures and more companies adopt this approach."

Read More

Related news

Catalent to open second clinical supply facility in China

Catalent to open second clinical supply facility in China

14 Nov 2018

Enables broader integrated solutions for global and local customers.

Read more 
EU FMD - time is running out!

EU FMD - time is running out!

13 Nov 2018

Companies that have left it too late to implement their own solution will have to rely on support from providers, whose resources are already in high demand as the deadline approaches.

Read more 
Record year for pharma packaging and drug delivery innovation

Record year for pharma packaging and drug delivery innovation

13 Nov 2018

Event sees more innovation centralising at the Paris hub with entries for the awards and Start-up Hub opening.

Read more 
Ardena cements growth and expansion with new HQ

Ardena cements growth and expansion with new HQ

12 Nov 2018

Larger headquarters will enable the company to free up space for additional laboratories and further expand capabilities.

Read more 
Virtual manufacturing system training service launches

Virtual manufacturing system training service launches

12 Nov 2018

Trainees are provided with real-world examples of process workflows.

Read more 
Hikma gets injectables foothold in Vietnam

Hikma gets injectables foothold in Vietnam

10 Nov 2018

Acquisition includes Medlac’s product portfolio of 23 injectable products and its pipeline.

Read more 
Concept Life Sciences extends GLP accreditation to support regulatory studies

Concept Life Sciences extends GLP accreditation to support regulatory studies

10 Nov 2018

Accreditation ensures quality and integrity of non-clinical laboratory studies to support pharmaceutical and biotech industries.

Read more 
Sartorius receives award for outstanding performance in its production chain

Sartorius receives award for outstanding performance in its production chain

8 Nov 2018

Company's manufacturing building for laboratory instruments in Göttingen wins the Global Excellence in Operations Award.

Read more 
Record growth at The Wasdell Group

Record growth at The Wasdell Group

7 Nov 2018

Despite Brexit looming, the company's EU & UK business has increased by almost 30% in the last 12 months.

Read more 
bioLIVE to merge with BioProduction Congress for 2019 event

bioLIVE to merge with BioProduction Congress for 2019 event

7 Nov 2018

BioProduction’s content platform will be added to the bioLIVE exhibition, creating one of the world’s largest event hubs for the bio industry.

Read more